🇺🇸 Interferon beta-1a (Avonex) in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abdominal Distension — 1 report (10%)
  2. Alopecia — 1 report (10%)
  3. Back Pain — 1 report (10%)
  4. Blood Pressure Decreased — 1 report (10%)
  5. Chest Pain — 1 report (10%)
  6. Diarrhoea — 1 report (10%)
  7. Dyspnoea — 1 report (10%)
  8. Ear Pain — 1 report (10%)
  9. Feeling Abnormal — 1 report (10%)
  10. Flushing — 1 report (10%)

Source database →

Interferon beta-1a (Avonex) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is Interferon beta-1a (Avonex) approved in United States?

Interferon beta-1a (Avonex) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Interferon beta-1a (Avonex) in United States?

Biogen is the originator. The local marketing authorisation holder may differ — check the official source linked above.